Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
Burlington Drug Company

FDA Inspection

•Burlington Drug Company•July 20, 2023

FDA Inspection 1211424 - Burlington Drug Company - July 20, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Burlington Drug Company, with an inspection on July 20, 2023, issued by the New England District Office.

Company: Burlington Drug Company
Inspection Date: July 20, 2023
Office: New England District Office

Open in Dashboard

ID · 9247a7bd-408b-4a78-9e1d-f777f4a98379

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

Home Platform Overview Media

KeyPedia™ Lite

Browse Hub Database Directory Records Companies Offices People Careers About Us Founding Team Meet Our Experts Partners

Legal & Ethics

Privacy Policy Terms of Service Our Values & Mission Code of Ethics & AI Policy

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1211424 - Burlington Drug Company - July 20, 2023 | KeyPedia